Paclitaxel with Cisplatin as Salvage Treatment for Patients with Previously Treated Advanced Transitional Cell Carcinoma of the Urothelial Tract
BACKGROUND: This study was performed to evaluate the safety and efficacy of paclitaxel with cisplatin as salvage therapy in patients previously treated with gemcitabine and cisplatin (G/C) for advanced transitional cell carcinoma (TCC) of the urothelial tract. METHODS: Twenty-eight patients with met...
| Published in: | Neoplasia: An International Journal for Oncology Research |
|---|---|
| Main Authors: | Ji Eun Uhm, Ho Yeong Lim, Won Seog Kim, Han Yong Choi, Hyun Moo Lee, Byeong-Bae Park, Keunchil Park, Won Ki Kang |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2007-01-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558607800121 |
Similar Items
Weekly Paclitaxel and Cisplatin in the Treatment of Elderly Advanced Non-small Cell Lung Cancer
by: Ying LIANG, et al.
Published: (2009-10-01)
by: Ying LIANG, et al.
Published: (2009-10-01)
PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01)
by: Cika Apriliana, et al.
Published: (2019-02-01)
Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel
by: Munazza Ahmed, et al.
Published: (2023-12-01)
by: Munazza Ahmed, et al.
Published: (2023-12-01)
PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)
Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis
by: Kwangrok Jung, et al.
Published: (2022-09-01)
by: Kwangrok Jung, et al.
Published: (2022-09-01)
Severe hypertriglyceridemia during treatment with intraperitoneal cisplatin and paclitaxel for advanced stage fallopian tube carcinoma
by: Megan Lander, et al.
Published: (2020-05-01)
by: Megan Lander, et al.
Published: (2020-05-01)
A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer
by: Haiyong WANG, et al.
Published: (2008-02-01)
by: Haiyong WANG, et al.
Published: (2008-02-01)
The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer
by: Junhwan Kim, et al.
Published: (2025-01-01)
by: Junhwan Kim, et al.
Published: (2025-01-01)
Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells
by: Jana Ismail, et al.
Published: (2025-02-01)
by: Jana Ismail, et al.
Published: (2025-02-01)
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma
by: Tetsushi Murakami, et al.
Published: (2021-09-01)
by: Tetsushi Murakami, et al.
Published: (2021-09-01)
Comparison of survival and adverse effect profile in patients with esophageal cancer treated with the combination of carboplatin and paclitaxel vs. 5-flourouracil and cisplatin
by: N. Nisar, et al.
Published: (2022-09-01)
by: N. Nisar, et al.
Published: (2022-09-01)
NIPEC with Single-Dose Intraperitoneal Cisplatin and Paclitaxel in Stage III Epithelial Ovarian Cancer
by: Elroy Saldanha, et al.
Published: (2023-01-01)
by: Elroy Saldanha, et al.
Published: (2023-01-01)
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity
by: Eleonora Pozzi, et al.
Published: (2023-01-01)
by: Eleonora Pozzi, et al.
Published: (2023-01-01)
Clinical Efficacy of Anlotinib Combined with Paclitaxel and Cisplatin as First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
by: YANG Xiaoli, et al.
Published: (2021-07-01)
by: YANG Xiaoli, et al.
Published: (2021-07-01)
Study to evaluate the acute toxicities and response to concurrent chemoradiotherapy with weekly cisplatin versus cisplatin and paclitaxel in locally advanced head-and-neck cancer
by: Tony Jacob, et al.
Published: (2023-01-01)
by: Tony Jacob, et al.
Published: (2023-01-01)
Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial
by: Xiao Yang, et al.
Published: (2025-08-01)
by: Xiao Yang, et al.
Published: (2025-08-01)
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis
by: Jia Zhao, et al.
Published: (2023-12-01)
by: Jia Zhao, et al.
Published: (2023-12-01)
Efficacy and Safety of Paclitaxel versus Cisplatin with Concurrent Radiotherapy in Central India Patients with Locally Advanced Head-and-neck Cancers: A Randomized, Open-label Study
by: Vijay Mahobia, et al.
Published: (2024-11-01)
by: Vijay Mahobia, et al.
Published: (2024-11-01)
Gemcitabine, dexamethasone, and cisplatin salvage in relapsed lymphomas: A single institutional experience
by: Avaronnan Manuprasad, et al.
Published: (2020-01-01)
by: Avaronnan Manuprasad, et al.
Published: (2020-01-01)
Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer
by: Avinash Khadela, et al.
Published: (2023-01-01)
by: Avinash Khadela, et al.
Published: (2023-01-01)
β<sub>3</sub> Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide
by: Emma Mitidieri, et al.
Published: (2022-07-01)
by: Emma Mitidieri, et al.
Published: (2022-07-01)
Porcine bladder urothelial, myofibroblast and detrusor muscle cells: characterisation and ATP release
by: Ying eCheng, et al.
Published: (2011-06-01)
by: Ying eCheng, et al.
Published: (2011-06-01)
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
by: Hui Li, et al.
Published: (2022-06-01)
by: Hui Li, et al.
Published: (2022-06-01)
Assessment of Effectiveness and Adverse Effect of New Combination Chemotherapy (irinotecan, cisplatin, and dexamethasone) in Relapse and Refractory Hodgkin Lymphoma
by: Mahdi Tabarraee, et al.
Published: (2023-07-01)
by: Mahdi Tabarraee, et al.
Published: (2023-07-01)
Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer
by: Gayle S. Jameson, et al.
Published: (2024-06-01)
by: Gayle S. Jameson, et al.
Published: (2024-06-01)
Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer
by: Xiangbo Kong, et al.
Published: (2017-04-01)
by: Xiangbo Kong, et al.
Published: (2017-04-01)
Urothelial dysfunction and sensory protein expressions in patients with urological or systemic diseases and hypersensitive bladder
by: Hueih-Ling Ong, et al.
Published: (2017-09-01)
by: Hueih-Ling Ong, et al.
Published: (2017-09-01)
Urothelial cancers of the bladder in young people
by: Živković Slađana, et al.
Published: (2003-01-01)
by: Živković Slađana, et al.
Published: (2003-01-01)
Gene Expression-Based Functional Differences between the Bladder Body and Trigonal Urothelium in Adolescent Female Patients with Micturition Dysfunction
by: Natalia Zeber-Lubecka, et al.
Published: (2022-06-01)
by: Natalia Zeber-Lubecka, et al.
Published: (2022-06-01)
Lifting and Lowering of Salvage Frame for Integral Salvage of Large Tonnage Wreck
by: WEI Liangmeng, ZHU Xiaodong, YI Qian, CUI Jin, ZHOU Dongrong
Published: (2023-10-01)
by: WEI Liangmeng, ZHU Xiaodong, YI Qian, CUI Jin, ZHOU Dongrong
Published: (2023-10-01)
Contractions of ex-vivo mouse bladder driven by activation of channelrhodopsin-2 expressed in urothelial cells
by: Firoj Alom, et al.
Published: (2025-10-01)
by: Firoj Alom, et al.
Published: (2025-10-01)
Role of hesperidin/hesperetin against chemotherapy-induced cardiotoxicity: a systematic review of non-clinical studies
by: Sina Shaernejad, et al.
Published: (2025-05-01)
by: Sina Shaernejad, et al.
Published: (2025-05-01)
Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration
by: Yoontaek Lee, et al.
Published: (2024-06-01)
by: Yoontaek Lee, et al.
Published: (2024-06-01)
nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma
by: Go Makimoto, et al.
Published: (2014-01-01)
by: Go Makimoto, et al.
Published: (2014-01-01)
Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
by: Yan D, et al.
Published: (2025-02-01)
by: Yan D, et al.
Published: (2025-02-01)
Urothelial Calcium-Sensing Receptor Modulates Micturition Function via Mediating Detrusor Activity and Ameliorates Bladder Hyperactivity in Rats
by: Wei-Yi Wu, et al.
Published: (2021-09-01)
by: Wei-Yi Wu, et al.
Published: (2021-09-01)
Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation
by: Hyun-Jung Kim, et al.
Published: (2015-01-01)
by: Hyun-Jung Kim, et al.
Published: (2015-01-01)
Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB–IVA cervical cancer: study protocol for a randomized controlled trial
by: Jing Li, et al.
Published: (2022-01-01)
by: Jing Li, et al.
Published: (2022-01-01)
Intravesical Instillation of Hyaluronic Acid With Epidermal Growth Factor for Restoring Urothelial Denudation and Alleviating Oxidative Stress in Lipopolysaccharide-Induced Interstitial Cystitis of Rats
by: Chih-Chieh Lin, et al.
Published: (2024-06-01)
by: Chih-Chieh Lin, et al.
Published: (2024-06-01)
Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Koichi Yagi, et al.
Published: (2021-07-01)
by: Koichi Yagi, et al.
Published: (2021-07-01)
Similar Items
-
Weekly Paclitaxel and Cisplatin in the Treatment of Elderly Advanced Non-small Cell Lung Cancer
by: Ying LIANG, et al.
Published: (2009-10-01) -
PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01) -
Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel
by: Munazza Ahmed, et al.
Published: (2023-12-01) -
PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01) -
Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis
by: Kwangrok Jung, et al.
Published: (2022-09-01)
